Calidi Biotherapeutics share price logo

Calidi Biotherapeutics

NASDAQ: CLDI

$1.33

-0.01

(-0.75%)

as on

Calidi Biotherapeutics Stock Performance

as on August 22, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $1.31
    $1.41
    downward going graph

    1.50%

    Downside

    6.02%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $1.48
    $81.84
    downward going graph

    -11.52%

    Downside

    6053.38%

    Upside

    downward going graph

Calidi Biotherapeutics share price movements today

Previous Close
$1.34
Open
$1.34
Volume
191.0K
Market Cap
$3.9M
Day's Low - High
$1.31 - $1.41
52 Week Low - High
$1.48 - $81.84

Calidi Biotherapeutics Historical Returns

1 Month Return
-16.42 %
3 Month Return
-46.46 %
1 Year Return
-98.12 %
3 Year Return
0 %
5 Year Return
0 %

Calidi Biotherapeutics Stock Fundamentals & Key Indicators

Check Calidi Biotherapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$3.9M

EPS (TTM)

-83.04

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-0.03

Industry PE ratio

-1.5966015625

PEG Ratio

-0.00014565020233728177

EBITDA

-17.2M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-372.86%

Calidi Biotherapeutics Stock Valuation

Track how Calidi Biotherapeutics P/E has moved over time to understand its valuation trends.

Calidi Biotherapeutics in the last 5 years

  • Overview

  • Trends

Lowest (-25.69x)

December 31, 2021

Industry (-1.60x)

December 31, 2025

Today (-0.20x)

December 31, 2025

Highest (-0.20x)

December 31, 2025

LowHigh

Today’s Price to Earnings Ratio: -0.20x

Calidi Biotherapeutics vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Calidi Biotherapeutics with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
BUY$3.9MNA-0.030.00%NA
BUY$43.7B669.3%NA0.00%NA
BUY$128.2B154.86%29.8286.04%NA
BUY$25.3B-84.24%-7.98-12.57%NA
BUY$82.7B24.1%19.2484.86%0.44999999999999996%

Stock Returns calculator for Calidi Biotherapeutics Stock including INR - Dollar returns

The Calidi Biotherapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

Calidi Biotherapeutics investment value today

Current value as on today

₹1,719

Returns

-₹98,281

(-98.28%)

Returns from Calidi Biotherapeutics Stock

-₹98,432 (-98.43%)

Dollar Impact

₹151 (+0.15%)

Analyst Recommendation on Calidi Biotherapeutics Stock

Based on 8 analysts

BUY

87.50%

Buy

12.50%

Hold

0.00%

Sell

Based on 8 analysts, 87.5% of analysts recommend a 'BUY' rating for Calidi Biotherapeutics. Average target price of $120

Calidi Biotherapeutics Share Price Target

Get share price movements and forecasts by analysts on Calidi Biotherapeutics.

What analysts predicted

98.89%UPSIDE

Target Price

$120

Current Price

$1.33

Analyzed by

8 Analysts

Target

$120.00

Calidi Biotherapeutics target price $120, a slight upside of 98.89% compared to current price of $1.33. According to 8 analysts rating.

Indian Investors' Interest in Calidi Biotherapeutics Stock

Search interest for Calidi Biotherapeutics Stock has increased by 80% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:80% versus previous 30 day period

Calidi Biotherapeutics Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Total Revenue
-
-
-
-
-
-
-
-
-
-
Gross Profit
0
0
0
-
-
-
-
-
-
0
Operating Income
-7
-9
-6
-5
-5
-5
-5
-5
-4
-4
EBITDA
-1
-7
-6
-5
-4
-4
-5
-4
-3
-3
Interest Expense
0
0
0
0
0
0
0
0
0
0
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-2
-8
-7
-5
-5
-5
-5
-5
-4
-4
Income Tax Expense
0
0
0
0
0
0
0
0
0
0
Net Income
-2
-8
-7
-5
-5
-4
-5
-5
-4
-4
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Calidi Biotherapeutics Annual Profit & Loss

All numbers in Millions USD

Dec 2020
Dec 2021
Dec 2022
Dec 2023
Mar 2025
Dec 2025
Total Revenue
-
0
0
-
-
-
Gross Profit
-
0
0
-1
-
-1
Operating Income
-6
-10
-23
-28
-21
-20
EBITDA
-6
-9
-24
-24
-19
-18
Interest Expense
0
0
0
3
0
0
Depreciation
0
0
0
1
1
1
Income Before Tax
-7
3
-25
-29
-22
-20
Income Tax Expense
0
0
0
0
0
0
Net Income
-7
-10
-25
-29
-22
-19
Net Profit Margin
0.00%
79.06%
-508.89%
0.00%
0.00%
0.00%

Calidi Biotherapeutics Quarterly Cash Flow

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Net Income
-2
-8
-7
-5
-5
-5
-5
-5
-4
-4
Operating Cash Flow
-13
-5
-3
-3
-4
-7
-4
-4
-5
-4
Investing Cash Flow
0
0
0
0
0
0
0
0
0
0
Financing Cash Flow
21
-2
3
3
6
8
0
9
0
5
Change in Cash
8
-8
0
0
1
0
-5
5
-4
1

Calidi Biotherapeutics Annual Cash Flow

All numbers in Millions USD

Dec 2020
Dec 2021
Dec 2022
Dec 2023
Mar 2025
Dec 2025
Net Income
-7
-10
-25
-29
-22
-20
Operating Cash Flow
-4
-7
-13
-26
-19
-21
Investing Cash Flow
0
0
0
0
0
0
Financing Cash Flow
4
9
12
29
27
17
Change in Cash
0
1
0
1
7
-3

Mutual Funds that own Calidi Biotherapeutics Stock

Check out the Mutual Funds with significant holdings in Calidi Biotherapeutics.

Funds
Holdings
Shares Held
Fidelity Concord Street Trust
3.261208%
39362
VANGUARD INDEX FUNDS
2.113463%
25509

Global Institutional Holdings in Calidi Biotherapeutics

Funds
Holdings
Vanguard
2.11%
Scott Kapnick
0.09%

Calidi Biotherapeutics News & Key Events

  • img

    Today's Timeline - 23 June

    Tue, 06:00 PM

    -

    Dr. Corsee Sanders appointed to Calidi Biotherapeutics' Board and Audit Committee, term expiring at 2029 annual meeting.

Insights on Calidi Biotherapeutics

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Revolution Medicines, Inc. Common Stock has given 472.1% return, outperforming this stock by 567.3%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, CLDI stock has moved down by -15.7%

About Calidi Biotherapeutics

Calidi Biotherapeutics, Inc., a biotechnology company, develops targeted therapies to deliver genetic medicines to distal sites of disease. The company offers CLD-101, which is in Phase 1b/2 clinical trial for the treatment of newly diagnosed high grade glioma, as well as in Phase 1 dose-escalation clinical trial for recurrent high-grade glioma; CLD-201 product for solid tumors, such as breast cancer, head and neck cancer, and sarcoma; and CLD-401 for the treatment of metastatic solid tumors. It also offers oncolytic virus platforms, such as NeuroNova and SuperNova. Calidi Biotherapeutics, Inc. was founded in 2014 and is headquartered in San Diego, California.
OrganisationCalidi Biotherapeutics
Headquarters4475 Executive Drive, San Diego, CA, United States, 92121
IndustryBiotechnology
CEODr. Eric E. Poma Ph.D.
E-voting on sharesClick here to vote

Key Management of Calidi Biotherapeutics

Name

Title

Dr. Guy Travis Clifton M.D.

Chief Medical Officer

Dr. Eric E. Poma Ph.D.

CEO & Director

Mr. Andrew C. Jackson

CFO & Corporate Secretary

Dr. Antonio Fernandez Santidrian Ph.D., Pharm.D.

Head of Technical Operations & Chief Scientific Officer

FAQs

What is Calidi Biotherapeutics share price today?

Calidi Biotherapeutics share price today is $1.33 as on at the close of the market. Calidi Biotherapeutics share today touched a day high of $1.41 and a low of $1.31.

What is the 52 week high and 52 week low for Calidi Biotherapeutics share?

Calidi Biotherapeutics share touched a 52 week high of $81.84 on and a 52 week low of $1.48 on . Calidi Biotherapeutics stock price today i.e. is closed at $1.33,which is 98.37% down from its 52 week high and -10.33% up from its 52 week low.

What is Calidi Biotherapeutics's market capitalisation today?

Calidi Biotherapeutics market capitalisation is $0.00T as on .

How to invest in Calidi Biotherapeutics Stock (CLDI) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Calidi Biotherapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Calidi Biotherapeutics Shares that will get you 1.1278 shares as per Calidi Biotherapeutics share price of $1.33 per share as on August 22, 2026 at 1:29 am IST.

What is the minimum amount required to buy Calidi Biotherapeutics Stock (CLDI) from India?

Indian investors can start investing in Calidi Biotherapeutics (CLDI) shares with as little as ₹95.685 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹956.85 in Calidi Biotherapeutics stock (as per the Rupee-Dollar exchange rate as on ). Based on Calidi Biotherapeutics share’s latest price of $1.33 as on August 22, 2026 at 1:29 am IST, you will get 7.5188 shares of Calidi Biotherapeutics. Learn more about fractional shares .